<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_SupBiotech-Paris_HomeEn"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:SupBiotech-Paris/HomeEn">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:SupBiotech-Paris/HomeEn&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:SupBiotech-Paris/HomeEn&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:SupBiotech-Paris/HomeEn&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:SupBiotech-Paris/HomeEn" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:SupBiotech-Paris/HomeEn</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><DIV id="menuhaut"><TABLE style="background-color: transparent;" cellpadding="3" cellspacing="20" align="center"><TBODY><TR><TH align="center"><A href="/Team:SupBiotech-Paris/HomeEn#drapeau" title="Team:SupBiotech-Paris/HomeEn">Home</A></TH><TH align="center"><A href="/Team:SupBiotech-Paris/Team#drapeau" title="Team:SupBiotech-Paris/Team">Team</A></TH><TH align="center"><A href="/Team:SupBiotech-Paris/Project_Management#drapeau" title="Team:SupBiotech-Paris/Project Management">Project Management</A></TH><TH align="center"><A href="/Team:SupBiotech-Paris/Gallery#drapeau" title="Team:SupBiotech-Paris/Gallery">Gallery</A></TH><TH align="center"><A href="/Team:SupBiotech-Paris/Acknowledgement#drapeau" title="Team:SupBiotech-Paris/Acknowledgement">Acknowledgement</A></TH></TR></TBODY></TABLE></DIV><DIV id="menu" style="margin-top: 315px; background: transparent;"><DIV id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Project</DIV><P><SPAN style="color: black;"><B>Introduction</B></SPAN><A href="/Team:SupBiotech-Paris/Current_therapies#drapeau" title="Team:SupBiotech-Paris/Current therapies">Current therapies</A><A href="/Team:SupBiotech-Paris/Gene_therapies#drapeau" title="Team:SupBiotech-Paris/Gene therapies">Gene therapies</A><SPAN style="color: black;"><B>DVS</B></SPAN><A href="/Team:SupBiotech-Paris/Concept#drapeau" title="Team:SupBiotech-Paris/Concept">Concept</A><A href="/Team:SupBiotech-Paris/Concept1#drapeau" title="Team:SupBiotech-Paris/Concept1">Tissue Vector</A><A href="/Team:SupBiotech-Paris/Concept2#drapeau" title="Team:SupBiotech-Paris/Concept2">Cell Vector</A><A href="/Team:SupBiotech-Paris/Concept3#drapeau" title="Team:SupBiotech-Paris/Concept3">Therapeutic plasmid</A><A href="/Team:SupBiotech-Paris/Conclusion1#drapeau" title="Team:SupBiotech-Paris/Conclusion1">Conclusion</A><SPAN style="color: black;"><B>Implementation</B></SPAN><A href="/Team:SupBiotech-Paris/Tissue_targeting#drapeau" title="Team:SupBiotech-Paris/Tissue targeting">Tissue targeting</A><A href="/Team:SupBiotech-Paris/Antitumor_action#drapeau" title="Team:SupBiotech-Paris/Antitumor action">Antitumor action</A><A href="/Team:SupBiotech-Paris/Treatement_modeling#drapeau" title="Team:SupBiotech-Paris/Treatement modeling">Treatment modeling</A><A href="/Team:SupBiotech-Paris/Conclusion3#drapeau" title="Team:SupBiotech-Paris/Conclusion3">Conclusion</A></P><DIV id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ressources</DIV><P><A href="/Team:SupBiotech-Paris/Biobricks#drapeau" title="Team:SupBiotech-Paris/Biobricks">BioBricks</A><A href="/Team:SupBiotech-Paris/Material_%26_Method#drapeau" title="Team:SupBiotech-Paris/Material &amp; Method">Material &amp; Method</A><A href="/Team:SupBiotech-Paris/Bibliography#drapeau" title="Team:SupBiotech-Paris/Bibliography">Bibliography</A></P><DIV id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ethics &amp; Safety</DIV><P><A href="/Team:SupBiotech-Paris/Ethic#drapeau" title="Team:SupBiotech-Paris/Ethic">Ethics</A><A href="/Team:SupBiotech-Paris/Safety#drapeau" title="Team:SupBiotech-Paris/Safety">Safety</A></P></DIV><H1><SPAN class="mw-headline" id="What_is_iGEM.3F"> What is iGEM? </SPAN></H1><P>International Genetically Engineered Machines (<A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A>) is an international Synthetic Biology competition, organized by the <A href="http://web.mit.edu/aboutmit" class="external text" rel="nofollow">Massachusetts Institute of Technology</A> (MIT), where over hundred students from the greatest universities in the world compete.</P><P><A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A> is based on the simple concept of gene standardization, <A href="http://partsregistry.org/Main_Page" class="external text" rel="nofollow">Biobricks</A>. Thus, each gene becomes simple to use and simple to arrange in order to make the engineering of living matter systematic.
The main objectives are to promote the development of open-source tools for biological engineering and thus contribute to the development of a society that uses biotechnologies.</P><P>For us, <A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A> is above all a tremendous professional and human experience. Students have to conceive a R&amp;D project, organize and lead an interdisciplinary program, work as a team, communicate and promote our work internationally.</P><P><SPAN style="float: right"><A href="/Team:SupBiotech-Paris/HomeEn#drapeau" title="Team:SupBiotech-Paris/HomeEn">Back to top</A></SPAN></P><H1><SPAN class="mw-headline" id="Why_are_we_participating.3F"> Why are we participating? </SPAN></H1><P><A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A> is a Synthetic Biology competition, in which each team has to create an innovative project and develop it in a laboratory. This project is interdisciplinary, it demands rigor and organizational skills when working. This envelops all the key points of our curriculum:
</P><DIV style="margin-left: 100px;"><P>- Innovation,
- Multidisciplinarity,
- Project management,
- Autonomy in our work,
- Scientific communication,
- And fun!</P></DIV><P><A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A> is also the opportunity to share our common interest with young scientists from around the world, meet our future partners and take part all together in the development of our discipline.</P><P><SPAN style="float: right"><A href="/Team:SupBiotech-Paris/HomeEn#drapeau" title="Team:SupBiotech-Paris/HomeEn">Back to top</A></SPAN></P><H1><SPAN class="mw-headline" id="The_.22DVS.22_Project"> The &quot;DVS&quot; Project </SPAN></H1><P>Within the framework of the <A href="https://2009.igem.org/Main_Page" class="external text" rel="nofollow">iGEM</A> competition, we have chosen to develop a project focused on health. Today, even though therapeutic products are becoming more and more efficient, they are becoming equally more and more fragile.
With this in mind, we have decided to develop a process enabling the protection of biological active ingredients, mainly nucleotide types. This process exists already; it’s what we call a <A href="/Team:SupBiotech-Paris/Introduction1#drapeau" title="Team:SupBiotech-Paris/Introduction1" class="mw-redirect">vector</A>. It can be biological, such as viruses, or chemical, such as polymeric nanoparticles. Whatever the nature of the vector, they raise many problems: stability, targeting, membrane passing, and immune reactions.
This is why we have tried to create the ideal vector: the best stability, the best targeting, capable of penetrating easily its target and especially capable of eluding the immune system. We have thus created a <A href="/Team:SupBiotech-Paris/Introduction1#DVS" title="Team:SupBiotech-Paris/Introduction1" class="mw-redirect">&quot;double vectorization system&quot;</A> (DVS) that uses jointly a bacteria and a phage. The <A href="/Team:SupBiotech-Paris/Concept1#drapeau" title="Team:SupBiotech-Paris/Concept1">first vector</A>, of bacterial type, is used to target the tissue and resist the immune system, whilst the <A href="/Team:SupBiotech-Paris/Concept2#drapeau" title="Team:SupBiotech-Paris/Concept2">second vector</A>, of phage type, is used to target the cell type and to penetrate the membranes. The combination of both systems offers an improvement of the intrinsic capacities of vectors, as well as new application possibilities.
Bearing in mind the public health problems of the world, we deemed interesting to apply our concept to lung cancer, which opens a new realm of therapeutic strategies to fight this physiopathology.
Through this WIKI, discover the construction of our project: from its conception to its realization.</P><P><SPAN style="float: right"><A href="/Team:SupBiotech-Paris/HomeEn#drapeau" title="Team:SupBiotech-Paris/HomeEn">Back to top</A></SPAN></P><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:SupBiotech-Paris/HomeEn">http://2009.igem.org/Team:SupBiotech-Paris/HomeEn</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:SupBiotech-Paris/HomeEn" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:SupBiotech-Paris/HomeEn" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:SupBiotech-Paris/HomeEn&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:SupBiotech-Paris/HomeEn&amp;oldid=169353" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>